Sandbox:Sara: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(108 intermediate revisions by the same user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{S.M.}}
{{CMG}}; {{AE}} {{S.M.}}


{| class="wikitable"
 
|+US FDA monograph list of active ingredients of sunscreen
 
!Type of filter
<ref name="pmid27261907">{{cite journal| author=Mao Y, Yang D, He J, Krasna MJ| title=Epidemiology of Lung Cancer. | journal=Surg Oncol Clin N Am | year= 2016 | volume= 25 | issue= 3 | pages= 439-45 | pmid=27261907 | doi=10.1016/j.soc.2016.02.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27261907  }} </ref>
! colspan="2" |Name of UV filter
 
!Concentration in percentage
[[File:Atypical Bcell gif.gif|thumb|200px|none|High-power field of peripheral blood smear revealing a large, atypical B cell with mild cytoplasmic expansion, coarse chromatin, multiple distinct nucleoli and peripheral vacuolation.[https://openi.nlm.nih.gov/detailedresult.php?img=PMC2944189_1752-1947-4-300-2&query=waldenstrom+macroglobulinaemia&it=xg&req=4&npos=17 Source: Charakidis M. et al, Department of Haematology-Oncology, Royal Hobart Hospital, Tasmania, 7000, Australia.]]]
|-
 
| rowspan="9" |'''Organic UVB Filters'''
 
| rowspan="2" |'''Cinnamates'''
{|  
|Octinoxate (octyl methoxycinnamate, Parsol MCX)
|+'''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders'''
|7.5%
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Criteria
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptomatic WM
|Cinoxate
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Asymptomatic WM
|3%
! style="background:#4479BA; color: #FFFFFF;" align="center" + |IgM-Related Disorders
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MGUS
| rowspan="2" |'''PABA derivatives'''
|15% Para-aminobenzoic acid (PABA)
|15%
|-
|Padimate O (octyl dimethyl PABA)
|8%
|-
| rowspan="3" |'''Salicylates'''
|Octisalate (octyl salicylate)
|5%
|-
|-
|Homosalate
! align="center" style="background:#DCDCDC;" + |IgM monoclonal protein
|15%
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | +
|-
|-
|Trolamine salicylate
! align="center" style="background:#DCDCDC;" + |Bone marrow infiltration
|12%
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | -
| style="background:#F5F5F5;" align="center" + | -
|-
|-
| rowspan="2" |'''Others'''
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to IgM
|Octocrylene
| style="background:#F5F5F5;" align="center" + | +
|10%
| style="background:#F5F5F5;" align="center" + | -
| style="background:#F5F5F5;" align="center" + | +
| style="background:#F5F5F5;" align="center" + | -
|-
|-
|Ensulizole (phenylbenzimidazole sulfonic acid)
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to tumor infiltration
|4%
| style="background:#F5F5F5;" align="center" + | +
|-
| style="background:#F5F5F5;" align="center" + | -
| rowspan="5" |'''Organic UVA Filters'''
| style="background:#F5F5F5;" align="center" + | -
| rowspan="3" |'''Benzophenones'''
| style="background:#F5F5F5;" align="center" + | -
|Oxybenzone (benzophenone-3)
|}<br />
|6%
|-
|Sulisobenzone (benzophenone-4)
|10%
|-
|Dioxybenzone (benzophenone-8
|3%
|-
| rowspan="2" |'''Others'''
|Butyl methoxydibenzoylmethane (avobenzone, Parsol 1789)
|3%
|-
|Meradimate (menthyl anthranilate)
|5%
|-
| rowspan="2" |'''Inorganic Filters'''
| colspan="2" |'''Titanium dioxide'''
|25%
|-
| colspan="2" |'''Zinc oxide'''
|25%
|}
 




Line 72: Line 47:




==References==
==Reference==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 18:18, 11 December 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]


[1]

High-power field of peripheral blood smear revealing a large, atypical B cell with mild cytoplasmic expansion, coarse chromatin, multiple distinct nucleoli and peripheral vacuolation.Source: Charakidis M. et al, Department of Haematology-Oncology, Royal Hobart Hospital, Tasmania, 7000, Australia.


Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders
Criteria Symptomatic WM Asymptomatic WM IgM-Related Disorders MGUS
IgM monoclonal protein + + + +
Bone marrow infiltration + + - -
Symptoms attributable to IgM + - + -
Symptoms attributable to tumor infiltration + - - -




Reference

  1. ↑ Mao Y, Yang D, He J, Krasna MJ (2016). "Epidemiology of Lung Cancer". Surg Oncol Clin N Am. 25 (3): 439–45. doi:10.1016/j.soc.2016.02.001. PMID 27261907.
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:Sara&oldid=1678042"